🇺🇸 FDA
Patent

US 11667692

T cell receptors recognizing HLA-CW8 restricted mutated KRAS

granted A61KA61K38/00A61P

Quick answer

US patent 11667692 (T cell receptors recognizing HLA-CW8 restricted mutated KRAS) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jun 01 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Jun 06 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 01 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K38/00, A61P, A61P35/00